Clinical trials recruiting in Limbaži, Latvia

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions recruiting in Limbaži, Latvia

Recruiting trials in Limbaži, Latvia

• Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
  NCT05712200 · Phase: Phase 3 · Ages: 65 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Limbaži, Latvia?

1 recruiting trial has at least one study site in Limbaži, Latvia.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.